NCT00004872|CompletedPhase 1
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
Phase I Study of Endostatin in Advanced Cancer Patients
Loading search results
Phase I Study of Endostatin in Advanced Cancer Patients
Sponsor study identifier
Secondary identifiers
interventional
N/A
1 country
1
Study Start
March 2000
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedRATIONALE: Endostatin may stop the growth of solid tumors by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of endostatin in treating patients who have advanced refractory solid tumors.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2000
Date type not reportedThis date has not been verified as actual or estimated.
March 7, 2000
Actual (reported)April 28, 2004
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, 53792, United States
Eder JP Jr, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DW. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol. 2002 Sep 15;20(18):3772-84. doi: 10.1200/JCO.2002.02.082.
James P. Thomas, MD, PhD
Ohio State University Comprehensive Cancer Center
First Submitted
March 7, 2000
First Posted
April 28, 2004
Study Start
March 2000
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
December 13, 2019
Record last verified: 2015-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Benzoylphenylurea in Treating Patients With Advanced Solid Tumors